Abstract:The growing use of molecular imaging helps to control and monitor dosage for increased safety and effectiveness. Molecular imaging agents become the scientific tools for moving a concept from bench work to clinic product development. This special issue provides original research and review of new trends in molecular imaging agent development. Among clinic molecular imaging modalities, radionuclide imaging technique is the most sensitive and could provide target-specific information. The radiotracer could non-invasively assess disease treatment endpoints which used to rely almost exclusively on biopsies and histopathological assays. L.-H. Shen et al. (Taiwan) reviewed molecular imaging in the diagnosis and management of CNS disorders. F.-L. Kong et al. (USA), N. Tsao et al. (USA), and C.-L. Ho et al. (Taiwan) report pharmacokinetics and dosimetry of molecular imaging compounds in oncology. M.-H. Liao et al. (Taiwan), X. Wang et al. (China), C. Wu et al. (China) and M. Tian et al. (USA) reported that molecular imaging techniques play a major role in the development of novel therapies since they measure target expressions (apoptosis, glycolysis) as well as function, pathway activities, and cell migration in the intact organism. Y.-F. Wang et al. and M.-Y. Chao et al. (Taiwan) described the kit probe for 99mTc-labeling which is crucial for centralized drug process. The kit probe may allow theranostic concept. A theranostic agent would be more accurate in the evaluation of patient response to treatment. The radiotracer could also be used for radionuclide therapy as reported by C. Wang et al. (China). Hybrid molecular imaging modalities (PET/CT, SPECT/CT) provide high-sensitivity functional and high-resolution anatomical imaging which are important in design-personalized treatment. M.-C. Chen et al. (Taiwan) reported the value of using I-131 NP-59 SPECT/CT to diagnose patients with subclinical or atypical features of primary aldosteronism. To proof of concept for molecular biology findings using different imaging modalities (optical, sonography) were described by Z. Pu et al. (China). In summary, molecular imaging enables the comprehensive characterization of therapeutic intervention and can be used in preclinical studies, pharmacokinetic studies, dose-finding studies, and proof-of-concept studies. Molecular imaging technologies promote the discovery and development of personalized medicine. Hong Zhang Mei Tian Carrio Ignasi Zhen Cheng Lie-Hang Shen David J. Yang

Application of Radionuclide Reporter Gene Imaging in Therapeutic Gene Monitoring

Advances of Reporter Gene Monitoring Stem Cell Therapy

Magnetic Resonance Imaging Permits In Vivo Monitoring Of Catheter-Based Vascular Gene Delivery

Applications of Molecular Imaging in Human Cancer Gene Therapy

Research of Ultrasound-Mediated Gene Delivery

Progress of Application Study on Sodium/iodide Symporter As a Radionuclide Imaging and Therapeutic Gene

In Vivo Imaging of Vascular Gene Delivery/expression: Current Status.

Assessment of therapeutic efficacy of liposomal nanoparticles mediated gene delivery by molecular imaging for cancer therapy.

Advances of Reporter Gene Imaging in Molecular Imaging

MRI Reporter Genes for Noninvasive Molecular Imaging

Imaging after Vascular Gene Therapy.

[Research Progress of Radionuclide Tracing in Small Interference RNA Imaging in Vivo].

An In Vitro RNA Editing-Based Reporter Assay for Transcriptional Activity of Therapeutic Gene in Gene Therapy Products

Somatostatin Receptor Based Imaging and Radionuclide Therapy

Research Progress of Imaging Receptor Tyrosine Kinase Targeted Drugs by Radionuclide

Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring

Molecular Image-Guided Theranostic and Personalized Medicine 2013

Advances in Microbubble-Assisted Ultrasound-Guided Gene Therapy: Mechanisms and Applications

Genetic Engineered Molecular Imaging Probes for Applications in Cell Therapy: Emphasis on MRI Approach.

Application of Radionuclide Tracing Technique on the Diagnosis and Treatment for Diseases

Functional Nanoparticles for Molecular Imaging Guided Gene Delivery